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Abstract
Chronic pelvic pain (CPP) in women is defined variably, but for clinical use it
is cyclical or non-cyclical pain of at least 3–6 months’ duration. It has major
impacts on individuals and society. There are both structural and idiopathic
causes. Whereas CPP is not curable in many cases, it is treatable. The
most promising approach is multidisciplinary patient-centered care
including cause-directed therapy, lifestyle changes, talking therapies,
meditation, acupuncture, and physiotherapy (this is not a complete list).
One of the most common structural causes for CPP is endometriosis. This
review investigates current scientific concepts and recent innovations in this
field as well as for CPP in general.
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Introduction
Chronic pelvic pain (CPP) is defined as cyclical or non-
cyclical pain of at least 6 months’ duration. Aspects of pain 
may include dysmenorrhea, dyspareunia, dysuria and dys-
chezia. Dysmenorrhea in isolation does not constitute CPP. 
CPP affects up to 24% of women worldwide1. It accounts for 
20% of gynecological clinic referrals2,3. It has a considerable 
impact on patients’ quality of life and their income, and annual 
costs to the NHS have been estimated at approximately £326 
million4 in addition to the costs to the public due to sick leave. 
One of the challenging issues is the long delay in women 
getting a diagnosis and accessing adequate care5.
In some patients, an underlying structural pelvic pathology 
can be identified (e.g. endometriosis, adenomyosis, or chronic 
pelvic inflammatory disease with adhesions or hydrosalpinx), 
but often pain is idiopathic6, meaning it is not due to a vis-
ible structural cause (e.g. bladder pain syndrome, irritable bowel 
syndrome, and pain memory), which describes the process 
of constant activation of the body’s pain perception system and 
applies to women with or without a structural disease such as 
endometriosis. It often occurs after an episode of acute pain, 
even if the painful stimulus has already been removed; mecha-
nisms have been reviewed by Flor et al.7. In fact, changes in the 
brain have been reported in endometriosis patients with CPP but 
not in asymptomatic women with endometriosis8.
In many cases, the pathology is multifactorial9. Follow up stud-
ies have shown that the surgical approach is frequently not 
curative. For instance, for endometriosis, 20–28% of patients 
do not experience a reduction in pain10,11 and some require 
another operation: 25.5% within 2 years and 40–50% after 
5 years12.
CPP is often resistant to surgical and medical treatment and 
appears to respond better to a multimodal, holistic approach 
rather than reliance on laparoscopy alone13,14. What is therefore 
required is an evidence base for aspects of a multidisciplinary 
approach with a focus on improving the patient’s quality of life, 
including self-management and complementary therapies, 
while also taking into account fertility plans. Like diabetes or 
hypertension, CPP is a chronic, idiopathic, and incurable but 
successfully treatable condition.
Recent advances in the management of 
endometriosis
Endometriosis definition
One of the commonest structural causes for CPP is endometrio-
sis. Endometriosis is a chronic inflammatory condition affect-
ing 6–10% of women of reproductive age, defined by the pres-
ence of endometrial-like tissue outside the uterus, commonly 
affecting the lining of the pelvis and the ovaries5 and frequently 
causing subfertility and pain during periods, sexual intercourse, 
and defecation (dyschezia). Pain can be managed with pain-
killers, hormonal interventions, and surgical removal using 
the laparoscopic approach. There is a considerable emotional 
and financial cost to patients and society: estimates of total 
direct costs ranged from $1,109 (£ 850) per patient per year 
in Canada to $12,118 (£ 9,298) per patient per year in the 
USA. Indirect costs of endometriosis ranged from $3,314 
(£ 2,542) per patient per year in Austria to $15,737 (£ 12,075) 
per patient per year in the USA15.
Delay in diagnosis
An average 7–9 years’ delay in accessing treatment for endome-
triosis in the UK16 leads to unnecessary suffering from a con-
dition that could be improved with appropriate management. 
Currently accurate non-invasive diagnostic tests or biomarkers 
are lacking. A recent James Lind Alliance Research Priority Set-
ting Initiative for Endometriosis identified “improved treatment 
and care of women with endometriosis” and a “non-invasive 
clinical prediction model” as top research priorities17.
A systematic search revealed no usable diagnostic algorithms 
to predict the disease successfully. However, an analysis of pri-
mary care records identified pain and menstrual symptoms 
occurring within the same year (odds ratio [OR] 6.5, 95% con-
fidence interval [CI]: 3.9 to 10.6) and lower gastrointestinal 
symptoms occurring within 90 days of gynecological pain 
(OR 6.1, 95% CI: 3.6 to 10.6) as predictive of the diagnosis of 
endometriosis several years before the formal diagnosis18.
Importantly, a normal ultrasound scan cannot rule out endome-
triosis and in the presence of symptoms suggestive of endome-
triosis can give false reassurance19. Specialized ultrasound 
approaches have been described20, which have an improved 
pick up rate.
Relationship between symptoms and severity
Traditionally, it has been emphasized that the extent of endome-
triosis can be disproportionate to the level of pain (women with 
severe endometriosis may be suffering little pain and women 
with a small disease volume may have high pain scores). 
Although this may still hold true for some women, newer evi-
dence indicates a relationship with more severe disease and higher 
scores of pain during periods, as identified in a meta-analysis 
that was carried out for the recent NICE guidelines on endome-
triosis19. Severe endometriosis infiltrating the bladder, bowel, 
and ureter can be suspected on clinical grounds, although symp-
toms can vary individually19. A pelvic assessment can point 
towards severe endometriosis (reduced organ mobility and 
tender nodularity in the posterior vaginal fornix, pain associ-
ated with pressure on the ovaries or uterine ligaments elicited 
during palpation, and endometriotic vaginal lesions visualised 
by examination with a speculum)19.
With the recognition of the need for a multidisciplinary team 
approach, care for women with severe endometriosis has been 
centralized in the UK to foster the evolution of highly special-
ized units with gynecologists, urologists, bowel surgeons, fer-
tility specialists, and specialist nurses providing integrated 
services19. Similar to the care of gynecological cancer, the care 
for women with severe endometriosis has been centralized to 
endometriosis centers, which underlie external quality con-
trol and prospective data collection21. Outcome measures for 
about 5,000 women with advanced endometriosis from a national 
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database and have recently been reviewed, showing sustained 
significant reductions in all pain types associated with endome-
triosis maintained at 2 years’ follow up. There is a significant 
improvement in quality of life, which is also sustained at 2 years.
Who gets better from surgery?
Laparoscopy can be diagnostic, therapeutic, or both. In the 
case of positive findings, a “see and treat approach” has been 
recommended as the gold standard22. This approach is currently 
under scientific scrutiny for women with mild endometriosis. In 
addition, guidelines on endometriosis management have been 
systematically assessed and their methodology was deemed 
substandard23.
Evidence from a randomized controlled trial (RCT) with pla-
cebo surgery control including 39 women with all stages of 
endometriosis has shown an improvement of symptoms in 
the treated group (16 of 20 [80%]) versus the placebo group 
(6 of 19 [32%])10. Quality of life measurements were also sig-
nificantly improved 6 months after excisional but not after 
placebo surgery.
However, surgery does not reduce pain in 20–28% of patients10. 
Secondary findings from observational single center stud-
ies indicate a graded response regarding pain reduction after 
endometriosis surgery, inversely related to disease severity11,24,25. 
One RCT found pain symptoms improved after endometrio-
sis surgery in significantly more patients with moderate and 
mild endometriosis (∼100% and ∼70%, respectively) than 
minimal disease (∼40%)11. In two other studies, women with 
deep infiltrating endometriosis experienced more pain reduction 
from surgery than those with superficial endometriosis25.
In order to determine which subgroup of women with CPP and 
mild forms of endometriosis benefit, or if there is any benefit at 
all for those women undergoing laparoscopic treatment, Horne 
et al. recently called for a trial randomizing such women to 
laparoscopy with and without treatment26. An NIHR-sponsored 
trial, aiming to create an algorithm to predict the improve-
ment in pain and quality of life after surgery using existing data, 
is underway (CRESCENDO NIHR PB-PG-0317-20018).
Whereas women with more severe endometriosis appear to have 
the best pain improvement after surgery, it has also been shown 
that the excision of endometriosis needs to be complete27,28 and 
in particular there needs to be the removal of deeply infiltrating 
implants not just that of ovarian cysts29.
Unfortunately, even with the full excision of endometriosis, 
women with severe forms require repeat surgery due to pain 
recurrence. Abbott et al.30 reported that if the revised Ameri-
can Fertility score (a grading system for endometriosis severity) 
was >70 points (indicating severe endometriosis), it was pre-
dictive of requiring further surgery. Interestingly, of the 
women who had further surgery, endometriosis was proven 
histologically in only 68%.
This points towards other causes at play that are responsible for 
ongoing pain which need to be addressed by other approaches. 
Reasons for residual pain can be endometriosis recurrence 
but also co-existent conditions associated with endometriosis 
including adenomyosis, irritable bowel syndrome, bladder pain 
syndrome, and pain memory.
Postoperative prevention of pain recurrence
Evidence of the value of postoperative medical treatment to 
prevent pain recurrence is inconclusive. Reviewing the existing 
literature, Somigliana et al.31 concluded that a short 3–6 months’ 
course of hormonal therapy with a GnRH agonist after 
surgery was of limited or no benefit for endometriosis in general 
and for deep peritoneal endometriosis in particular. On the 
other hand, they reviewed evidence indicating a beneficial 
effect of prolonged hormonal therapy after surgery for deep 
endometriosis. There may be a role for aromatase inhibitors, but 
more good-quality studies are required32.
The value of postoperative adjuvant therapy may relate to 
the completeness of surgery. In a retrospective study of 93 
patients28, women with incomplete excision who received post-
operative GnRH agonist had a post-treatment improvement 
of a 10 cm visual analogue scale (VAS) score similar to that of 
patients who had undergone complete excision (4.5±3.2 versus 
5.6±3.9, P = 0.272), whereas in patients who had under-
gone complete excision there was no added benefit during an 
18-month follow up period.
A health economics analysis based on historical data from 
1,106 women with first diagnosis of endometriosis observed 
between 1979 and 20033 was used for a recent Chinese analysis34. 
This analysis suggested a cost saving of over $6,000 per patient 
who received 6 months of postoperative treatment with a 
GnRH agonist. Given the recent technical advances in sur-
gery and centralization of care, it can be speculated that current 
surgery leads more often to complete excision with a reduced 
cost benefit.
Pre-empt (NIHR ISRCTN97865475), a current RCT, has been 
designed to examine the role of progesterone-containing con-
traceptives in reducing recurrence after surgery. Participants 
are randomly allocated to take either long-acting progestogens 
(either as 3-monthly injections or as a coil, which is inserted 
into the womb, where it remains for 5 years) or long-term 
treatment with the oral contraceptive pill. Results are awaited.
Are there effective holistic and psychological 
approaches to endometriosis and chronic pelvic 
pain, including self-management?
Given the portion of non-responders to surgery (reviewed 
by Horne26) and the recurrence of pain, even if there is no 
recurrence of endometriosis in 23%, patients are calling for 
evidence-based approaches that do not require surgery or 
taking hormones (author’s focus group with patients from 
endometriosis UK, 2018). It is well known that endometriosis 
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and CPP negatively impact mental health and quality of life, 
suggesting that affected women may have an increased risk of 
developing psychological suffering as well as of sexual problems35 
due to the presence of pain.
Diet
By far the largest study on diet and endometriosis is based on 
the dataset of the Nurses’ Health Study (n = 3,800 with laparo-
scopically confirmed endometriosis)36. Women consuming more 
than two servings per day of red meat had a 56% higher risk of 
endometriosis (95% CI: 1.22–1.99; P <0.0001) compared to those 
consuming one or fewer serving per week. Intakes of poultry, 
fish, shellfish, and eggs were unrelated to endometriosis risk.
A systematic review further reported ORs for the following 
foods and the presence of endometriosis: calcium intake OR: 
0.99 (95% CI: 0.83–1.18), milk OR: 0.90 (95% CI: 0.65–1.23), 
eggs OR: 1.01 (95% CI: 0.81–1.28), bacon OR: 1.26 (95% 
CI: 0.60–2.65), and red meat OR: 1.26 (95% CI: 0.73–2.18)37. 
Prospective trials investigating the effectiveness of dietary 
interventions are needed.
Exercise
With endometriosis being both an inflammatory and an estro-
gen-dependent disease, it seems worthwhile to examine the 
effect of exercise, which is known to suppress both pathways. 
A systematic review of 3,355 women with endometriosis who 
had been doing recent physical activity and 4,600 cases who had 
been doing physical activity in the past reported that a pooled 
estimate of adjusted ORs for current exercise appeared to 
convey a significantly protective effect (OR: 0.69, CI: 0.53–0.89, 
Z = 2.83, P = 0.005), but the authors discuss their findings with 
a caveat because the overall estimates did not reach levels 
of significance38.
Acupuncture
A historic Cochrane systematic review of acupuncture in 
endometriosis39 was able to include only a single study40 with 
67 participants randomized to acupuncture or Chinese herbal 
medicine. Dysmenorrhea scores were lower in the acupuncture 
group (mean difference –4.81 points, 95% CI: –6.25 to –3.37, 
P <0.00001) using the 15-point Chinese Medicine for Treatment 
of Pelvic Endometriosis scale.
Since then, a systematic review41 of two sham-controlled RCTs 
and a retrospective study of 121 women with all stages of endome-
triosis41–43 suggested a decrease in pain following acupuncture, 
although numerical data could not be meta-analyzed owing 
to the way outcomes were reported.
A further systematic review included two placebo-controlled 
RCTs43,44 on acupuncture in endometriosis showing that the 
56 included endometriosis patients had more pain reduc-
tion with acupuncture than placebo (RR: –1.93, 95% CI: 3.33 
to 0.53, P = 0.007)45. A well-designed RCT protocol for a 
forthcoming study is underway46.
Psychological interventions
Given the association with stress and a pro-inflammatory 
immune response in addition to the poorer mental health that can 
be associated with endometriosis, psychological approaches 
appear to be promising. A current systematic review of psy-
chological and mind–body interventions for endometriosis 
with narrative synthesis due to the variety of study designs47 
identified three RCTs, the remaining nine being non-randomized.
Psychotherapy with somatosensory stimulation48 including a 
combination of Chinese medicine, hypnotherapy, cognitive 
behavioral therapy, and mindfulness was delivered in ses-
sions over 3 months (n = 35) compared to waitlist controls 
(n = 32). The intervention group had reductions in maximal glo-
bal pain (mean group difference –2.1, 95% CI: –3.4 to –0.8, 
P = 0.002), average global pain (–2.5, 95% CI: –3.5 to –1.4, 
P <0.001), pelvic pain (–1.4, 95% CI: –2.7 to –0.1, P = 0.036), 
and dyschezia (–3.5, 95% CI: –5.8 to –1.3, P = 0.003) and 
improvements in physical quality of life (3.8, 95% CI: 0.5–7.1, 
P = 0.026) and mental quality of life (5.9, 95% CI: 0.6–11.3, 
P = 0.031).
In another study, 40 women were randomly divided into two 
groups: an intervention group of women who were allocated 
to hatha yoga sessions twice a week for 8 weeks (n = 28) and a 
control group of women who did not practice yoga (n = 12). 
Daily pain was significantly reduced in the yoga group 
compared with those who did not practice yoga (P = 0.0007)49.
The third study randomly assigned 100 consecutive Chi-
nese endometriosis patients to a progressive muscle relaxa-
tion (PMR) group (n = 50) and a control group (n = 50). Over 
12 weeks, both groups received one dose of depot leuprolide, 
and the PMR group received 12 weeks of additional PMR 
training. Anxiety levels and depression were measured with 
validated instruments. The PMR group showed significant 
improvement in state anxiety, trait anxiety, and depression 
after intervention (P <0.05)50.
There is growing interest in using mindfulness-based interventions, 
which have been shown to be effective in other types of chronic 
pain51. One of the uncontrolled studies from the previous sys-
tematic review is that of Hansen et al.52, who reported sustained 
long-term effects (6-year follow-up) of a 10-session mindfulness- 
based psychological intervention for a series of 10 women 
with endometriosis-related CPP and improved quality of life.
Mindfulness meditation taught and delivered by a smart-
phone application has been investigated in a three-arm 
RCT (n = 90 women with chronic pain with and without 
endometriosis) compared to PMR and treatment as usual. The 
publication of results is awaited53.
Recent advances in the management of chronic pain
Laparoscopy is a costly and invasive “gold standard’ to 
diagnose causes of CPP. The recently completed MEDAL 
Page 5 of 8
F1000Research 2020, 9(F1000 Faculty Rev):83 Last updated: 04 FEB 2020
study54 on 291 women with CPP aimed to determine the propor-
tion of women with CPP for whom MRI is accurate enough to 
replace laparoscopy following evaluation of their symptoms. The 
authors concluded that MRI scans are not sufficiently accurate to 
find the cause of CPP in women and should not replace laparos-
copy.
A Cochrane review from 201455, which included 13 publica-
tions of non-surgical interventions for the management of CPP, 
reported moderate-quality evidence to support progestogen 
as an option for CPP at the cost of side effects such as weight 
gain and bloating. Other interventions such as a comparison 
of goserelin with progestogen, gabapentin with amitriptyline, 
“reassurance ultrasound” versus “wait and see”, and writing 
therapy versus non-disclosure provided too low-quality 
evidence or was drawn from a single study only. Thus, no 
recommendations could be made, and the authors called for RCTs 
of other medical, lifestyle, and psychological interventions.
Similarly, another Cochrane review on oral contraception for 
the treatment of endometriosis-related pain56 concluded that the 
limited evidence from two trials at high risk of bias provided 
insufficient evidence to make a judgement on the effectiveness 
of the combined oral contraceptive pill (COCP) compared with 
placebo.
To provide an effective oral treatment to alleviate pain in women 
with CPP in the absence of any obvious pelvic pathology, a 
double-blind placebo-controlled randomized multicenter clini-
cal trial called GAPP is underway. A total of 300 women with 
CPP and a normal laparoscopy will be randomized to gabap-
entin or placebo and their treatment will be titrated over a 
4-week period to a maximum of 2,700 mg or placebo equivalent 
and maintained at that dose for 12 weeks. Average and worst 
pain scores will be measured by validated questionnaires. 
The results are expected soon57.
A review on CPP management would not be complete 
without the mention of the role of physiotherapy, including 
treatment of myofascial trigger points, pelvic floor relaxa-
tion, and biofeedback. However, it is difficult to examine 
these treatments as stand-alone interventions, and a recent 
systematic review called for well-conducted, larger trials58.
Future research should be directed at helping to shorten the 
delay in making the diagnosis of endometriosis, involving pri-
mary and secondary care. Women who benefit most from sur-
gery should be identified through systematic review of evidence, 
new RCTs, or analysis of existing data (such as CRESCENDO 
NIHR PB-PG-0317-20018). Lifestyle measures such as diet and 
exercise for CPP need to be prospectively examined in RCTs.
In conclusion, progress is being made in creating better 
awareness of endometriosis, identifying approaches to diagnose 
endometriosis earlier, and enabling women to access effective 
treatment. However, not all women with CPP with or without 
endometriosis will benefit from surgery, and a multidisciplinary 
patient-centered approach is needed. Whereas evidence for 
non-surgical approaches is increasing, more RCTs on which to 
base recommendations are needed.
Abbreviations
CI, confidence interval; CPP, chronic pelvic pain; OR, odds 
ratio; PMR, progressive muscle relaxation; RCT, randomized 
controlled trial.
References F1000 recommended
1. Latthe P, Latthe M, Say L, et al.: WHO systematic review of prevalence of 
chronic pelvic pain: a neglected reproductive health morbidity. BMC Public 
Health. 2006; 6: 177.  
PubMed Abstract | Publisher Full Text | Free Full Text 
2. Howard FM: The role of laparoscopy in chronic pelvic pain: promise and 
pitfalls. Obstet Gynecol Surv. 1993; 48(6): 357–87.  
PubMed Abstract | Publisher Full Text 
3. Ayorinde AA, Macfarlane GJ, Saraswat L, et al.: Chronic pelvic pain in women: 
an epidemiological perspective. Womens Health (Lond). 2015; 11(6): 851–64. 
PubMed Abstract | Publisher Full Text 
4. Curtis L: Unit Costs of Health and Social Care 2014 Personal Social Services 
Research Unit, University of Kent, Canterbury. University of Kent, Canterbury; 
2014.  
Reference Source
5. Viganò P, Parazzini F, Somigliana E, et al.: Endometriosis: epidemiology and 
aetiological factors. Best Pract Res Clin Obstet Gynaecol. 2004; 18(2): 177–200. 
PubMed Abstract | Publisher Full Text 
6. Tirlapur SA, Priest L, Daniels JP, et al.: How do we define the term idiopathic? 
Curr Opin Obstet Gynecol. 2013; 25(6): 468–73.  
PubMed Abstract | Publisher Full Text 
7. Flor H: Painful memories. Can we train chronic pain patients to ‘forget’ their 
pain? EMBO Rep. 2002; 3(4): 288–91.  
PubMed Abstract | Publisher Full Text | Free Full Text 
8. As-Sanie S, Harris RE, Napadow V, et al.: Changes in regional gray matter 
volume in women with chronic pelvic pain: a voxel-based morphometry study. 
Pain. 2012; 153(5): 1006–14.  
PubMed Abstract | Publisher Full Text | Free Full Text 
9. Yosef A, Allaire C, Williams C, et al.: Multifactorial contributors to the severity of 
chronic pelvic pain in women. Am J Obstet Gynecol. 2016; 215(6): 760.e1–760.e14. 
PubMed Abstract | Publisher Full Text 
10. Abbott J, Hawe J, Hunter D, et al.: Laparoscopic excision of endometriosis: a 
randomized, placebo-controlled trial. Fertil Steril. 2004; 82(4): 878–84.  
PubMed Abstract | Publisher Full Text 
11. Banerjee S, Ballard KD, Lovell DP, et al.: Deep and superficial endometriotic 
disease: the response to radical laparoscopic excision in the treatment of 
chronic pelvic pain. Gynecol Surg. 2006; 3(3): 199–205.  
Publisher Full Text 
12. Guo SW: Recurrence of endometriosis and its control. Hum Reprod Update. 
2009; 15(4): 441–61.  
PubMed Abstract | Publisher Full Text 
13. Peters AA, van Dorst E, Jellis B, et al.: A randomized clinical trial to compare two 
different approaches in women with chronic pelvic pain. Obstet Gynecol. 1991; 
77(5): 740–4.  
PubMed Abstract | Publisher Full Text 
14.  Katz L, Fransson A, Zacharias R: The Development of a Novel 
Interdisciplinary Chronic Pelvic Pain Program. Can J Pain. 2019.  
F1000 Recommendation 
15. Soliman AM, Yang H, Du EX, et al.: The direct and indirect costs associated 
with endometriosis: a systematic literature review. Hum Reprod. 2016; 31(4): 
712–22.  
PubMed Abstract | Publisher Full Text 
16. Jan H, Shakir F, Haines P, et al.: Diagnostic Delay for Superficial and Deep 
Endometriosis in the United Kingdom: A First Quantitative Study. J Minim 
Page 6 of 8
F1000Research 2020, 9(F1000 Faculty Rev):83 Last updated: 04 FEB 2020
Invasive Gynecol. 2014; 21(6): S127.  
Publisher Full Text 
17.  Horne AW, Saunders PTK, Abokhrais IM, et al.: Top ten endometriosis 
research priorities in the UK and Ireland. Lancet. 2017; 389(10085): 2191–2. 
PubMed Abstract | Publisher Full Text | F1000 Recommendation 
18.  Burton C, Iversen L, Bhattacharya S, et al.: Pointers to earlier diagnosis of 
endometriosis: a nested case-control study using primary care electronic 
health records. Br J Gen Pract. 2017; 67(665): e816–e823.  
PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation 
19. Endometriosis: diagnosis and management, NICE guideline [NG73]. 2017. 
Reference Source
20.  Leonardi M, Condous G: How to perform an ultrasound to diagnose 
endometriosis. Aust J Ultras Med. 2018; 21(2): 61–9.  
Publisher Full Text | F1000 Recommendation 
21.  Byrne D, Curnow T, Smith P, et al.: Laparoscopic excision of deep 
rectovaginal endometriosis in BSGE endometriosis centres: a multicentre 
prospective cohort study. BMJ Open. 2018; 8(4): e018924.  
PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation 
22. Ball E, Koh C, Janik G, et al.: Gynaecological laparoscopy: ‘see and treat’ 
should be the gold standard. Curr Opin Obstet Gynecol. 2008; 20(4): 325–30. 
PubMed Abstract | Publisher Full Text 
23.  Appleyard TL, Mann CH, Khan KS: Guidelines for the management of pelvic 
pain associated with endometriosis: a systematic appraisal of their quality. 
BJOG. 2006; 113(7): 749–57.  
PubMed Abstract | Publisher Full Text | F1000 Recommendation 
24. Vercellini P, Fedele L, Aimi G, et al.: Reproductive performance, pain recurrence 
and disease relapse after conservative surgical treatment for endometriosis: 
the predictive value of the current classification system. Hum Reprod. 2006; 
21(10): 2679–85.  
PubMed Abstract | Publisher Full Text 
25. Milingos S, Protopapas A, Kallipolitis G, et al.: Endometriosis in patients with 
chronic pelvic pain: is staging predictive of the efficacy of laparoscopic 
surgery in pain relief? Gynecol Obstet Invest. 2006; 62(1): 48–54.  
PubMed Abstract | Publisher Full Text 
26. Horne AW, Daniels J, Hummelshoj L, et al.: Surgical removal of superficial 
peritoneal endometriosis for managing women with chronic pelvic pain: time 
for a rethink? BJOG. 2019; 126(12): 1414–6.  
PubMed Abstract | Publisher Full Text | Free Full Text 
27. Angioni S, Pontis A, Dessole M, et al.: Pain control and quality of life after 
laparoscopic en-block resection of deep infiltrating endometriosis (DIE) vs. 
incomplete surgical treatment with or without GnRHa administration after 
surgery. Arch Gynecol Obstet. 2015; 291(2): 363–70.  
PubMed Abstract | Publisher Full Text 
28. Cao Q, Lu F, Feng WW, et al.: Comparison of complete and incomplete excision 
of deep infiltrating endometriosis. Int J Clin Exp Med. 2015; 8(11): 21497–506. 
PubMed Abstract | Free Full Text 
29. Hidaka T, Nakashima A, Hashimoto Y, et al.: Effects of laparoscopic radical 
surgery for deep endometriosis on endometriosis-related pelvic pain. Minim 
Invasive Ther Allied Technol. 2012; 21(5): 355–361.  
PubMed Abstract | Publisher Full Text 
30. Abbott JA, Hawe J, Clayton RD, et al.: The effects and effectiveness of 
laparoscopic excision of endometriosis: a prospective study with 2–5 year 
follow-up. Hum Reprod. 2003; 18(9): 1922–7.  
PubMed Abstract | Publisher Full Text 
31. Somigliana E, Busnelli A, Benaglia L, et al.: Postoperative hormonal therapy after 
surgical excision of deep endometriosis. Eur J Obstet Gynecol Reprod Biol. 
2017; 209: 77–80.  
PubMed Abstract | Publisher Full Text 
32. Nawathe A, Patwardhan S, Yates D, et al.: Systematic review of the effects of 
aromatase inhibitors on pain associated with endometriosis. BJOG. 2008; 
115(7): 818–22.  
PubMed Abstract | Publisher Full Text 
33. Busacca M, Chiaffarino F, Candiani M, et al.: Determinants of long-term clinically 
detected recurrence rates of deep, ovarian, and pelvic endometriosis. Am J 
Obstet Gynecol. 2006; 195(2): 426–32.  
PubMed Abstract | Publisher Full Text 
34.  Wu B, Yang Z, Tobe RG, et al.: Medical therapy for preventing recurrent 
endometriosis after conservative surgery: a cost-effectiveness analysis. 
BJOG. 2018; 125(4): 469–77.  
PubMed Abstract | Publisher Full Text | F1000 Recommendation 
35. Moradi M, Parker M, Sneddon A, et al.: Impact of endometriosis on women’s 
lives: a qualitative study. BMC Womens Health. 2014; 14: 123.  
PubMed Abstract | Publisher Full Text | Free Full Text 
36.  Yamamoto A, Harris HR, Vitonis AF, et al.: A prospective cohort study of 
meat and fish consumption and endometriosis risk. Am J Obstet Gynecol. 2018; 
219(2): 178.e1–178.e10.  
PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation 
37. Hoorsan H, Mirmiran P, Chaichian S, et al.: Diet and Risk of Endometriosis: A 
Systematic Review and Meta-Analysis Study. Iran Red Crescent Med J. 2017; 
19(9): e41248.  
Publisher Full Text 
38. Ricci E, Viganò P, Cipriani S, et al.: Physical activity and endometriosis risk in 
women with infertility or pain: Systematic review and meta-analysis. Medicine 
(Baltimore). 2016; 95(40): e4957.  
PubMed Abstract | Publisher Full Text | Free Full Text 
39. Zhu X, Hamilton KD, McNicol ED: Acupuncture for pain in endometriosis. 
Cochrane Database Syst Rev. 2011; (9): CD007864.  
PubMed Abstract | Publisher Full Text 
40. Xiang D, Situ Y, Liang X, et al.: Ear acupuncture therapy for 37 cases of 
dysmenorrhea due to endometriosis. J Tradit Chin Med. 2002; 22(4): 282–5. 
PubMed Abstract 
41. Highfield ES, Laufer MR, Schnyer RN, et al.: Adolescent endometriosis-related 
pelvic pain treated with acupuncture: two case reports. J Altern Complement 
Med. 2006; 12(3): 317–22.  
PubMed Abstract | Publisher Full Text 
42. Rubi-Klein K, Kucera-Sliutz E, Nissel H, et al.: Is acupuncture in addition to 
conventional medicine effective as pain treatment for endometriosis? A 
randomised controlled cross-over trial. Eur J Obstet Gynecol Reprod Biol. 2010; 
153(1): 90–3.  
PubMed Abstract | Publisher Full Text 
43. Wayne PM, Kerr CE, Schnyer RN, et al.: Japanese-style acupuncture for 
endometriosis-related pelvic pain in adolescents and young women: results 
of a randomized sham-controlled trial. J Pediatr Adolesc Gynecol. 2008; 21(5): 
247–57.  
PubMed Abstract | Publisher Full Text | Free Full Text 
44. de Sousa TR, de Souza BC, Zomkowisk K, et al.: The effect of acupuncture on 
pain, dyspareunia, and quality of life in Brazilian women with endometriosis: 
A randomized clinical trial. Complement Ther Clin Pract. 2016; 25: 114–21. 
Publisher Full Text 
45.  Mira TAA, Buen MM, Borges MG, et al.: Systematic review and  
meta-analysis of complementary treatments for women with symptomatic 
endometriosis. Int J Gynaecol Obstet. 2018; 143(1): 2–9.  
PubMed Abstract | Publisher Full Text | F1000 Recommendation 
46. Liang R, Li P, Peng X, et al.: Efficacy of acupuncture on pelvic pain in  
patients with endometriosis: study protocol for a randomized, single-blind, 
multi-center, placebo-controlled trial. Trials. 2018; 19(1): 314.  
PubMed Abstract | Publisher Full Text | Free Full Text 
47.  Evans S, Fernandez S, Olive L, et al.: Psychological and mind-body 
interventions for endometriosis: A systematic review. J Psychosom Res. 2019; 
124: 109756.  
PubMed Abstract | Publisher Full Text | F1000 Recommendation 
48. Meissner K, Schweizer-Arau A, Limmer A, et al.: Psychotherapy With 
Somatosensory Stimulation for Endometriosis-Associated Pain: A 
Randomized Controlled Trial. Obstet Gynecol. 2016; 128(5): 1134–42.  
PubMed Abstract | Publisher Full Text 
49.  Gonçalves AV, Barros NF, Bahamondes L: The Practice of Hatha Yoga for the 
Treatment of Pain Associated with Endometriosis. J Altern Complement Med. 
2017; 23(1): 45–52.  
PubMed Abstract | Publisher Full Text | F1000 Recommendation 
50. Zhao L, Wu H, Zhou X, et al.: Effects of progressive muscular relaxation 
training on anxiety, depression and quality of life of endometriosis patients 
under gonadotrophin-releasing hormone agonist therapy. Eur J Obstet Gynecol 
Reprod Biol. 2012; 162(2): 211–5.  
PubMed Abstract | Publisher Full Text 
51. Ball EF, Nur Shafina Muhammad Sharizan E, Franklin G, et al.: Does mindfulness 
meditation improve chronic pain? A systematic review. Curr Opin Obstet 
Gynecol. 2017; 29(6): 359–66.  
PubMed Abstract | Publisher Full Text 
52. Hansen KE, Kesmodel US, Kold M, et al.: Long-term effects of mindfulness-
based psychological intervention for coping with pain in endometriosis: A 
six-year follow-up on a pilot study. give Nord Psychol. 2016; 69(1): 100–9.  
Publisher Full Text 
53. Ball E, Newton S, Kahan BC, et al.: Smartphone App Using Mindfulness 
Meditation for Women With Chronic Pelvic Pain (MEMPHIS): Protocol for a 
Randomized Feasibility Trial. JMIR Res Protoc. 2018; 7(1): e8.  
PubMed Abstract | Publisher Full Text | Free Full Text 
54. Khan KS, Tryposkiadis K, Tirlapur SA, et al.: MRI versus laparoscopy to diagnose 
the main causes of chronic pelvic pain in women: a test-accuracy study and 
economic evaluation. Health Technol Assess. 2018; 22(40): 1–92.  
PubMed Abstract | Publisher Full Text | Free Full Text 
55. Cheong YC, Smotra G, Williams AC: Non-surgical interventions for the 
management of chronic pelvic pain. Cochrane Database Syst Rev. 2014; (3): 
CD008797.  
PubMed Abstract | Publisher Full Text 
56. Brown J, Crawford TJ, Datta S, et al.: Oral contraceptives for pain associated 
with endometriosis. Cochrane Database Syst Rev. 2018; 5(Suppl 1): CD001019.  
PubMed Abstract | Publisher Full Text | Free Full Text 
57. Vincent K, Baranowski A, Bhattacharya S, et al.: GaPP2, a multicentre randomised 
controlled trial of the efficacy of gabapentin for the management of chronic 
pelvic pain in women: study protocol. BMJ Open. 2018; 8(1): e014924.  
PubMed Abstract | Free Full Text 
58. Klotz SGR, Schön M, Ketels G, et al.: Physiotherapy management of patients 
with chronic pelvic pain (CPP): A systematic review. Physiother Theory Pract. 
2019; 35(6): 516–32.  
PubMed Abstract | Publisher Full Text 
Page 7 of 8
F1000Research 2020, 9(F1000 Faculty Rev):83 Last updated: 04 FEB 2020
 Open Peer Review
  Current Peer Review Status:
Editorial Note on the Review Process
 are written by members of the prestigious  . They are commissioned andF1000 Faculty Reviews F1000 Faculty
are peer reviewed before publication to ensure that the final, published version is comprehensive and accessible.
The reviewers who approved the final version are listed with their names and affiliations.
The reviewers who approved this article are:
Version 1
The benefits of publishing with F1000Research:
Your article is published within days, with no editorial bias
You can publish traditional articles, null/negative results, case reports, data notes and more
The peer review process is transparent and collaborative
Your article is indexed in PubMed after passing peer review
Dedicated customer support at every stage
For pre-submission enquiries, contact   research@f1000.com
 Paul J Yong
Department of Obstetrics and Gynecology, University of British Columbia, Women's Health Research
Institute, BC Women's Hospital and Health Center, Vancouver, Canada
 No competing interests were disclosed.Competing Interests:
1
 Délio Marques Conde
Department of Gynecology and Obstetrics, Federal University of Goiás, Goiás, Brazil
 No competing interests were disclosed.Competing Interests:
2
Page 8 of 8
F1000Research 2020, 9(F1000 Faculty Rev):83 Last updated: 04 FEB 2020
